Abstract: The present invention provides: a method for producing a heparosan compound having an isomerized hexulonic acid residue which has improved C5-epimerization efficiency; and a method for producing heparan sulfate. More specifically the present invention provides a method for producing a heparosan compound having an isomerized hexulonic acid residue said method comprising producing the heparosan compound having an isomerized hexulonic acid residue from a heparosan compound in the presence of a protein selected from the group consisting of the following proteins (A) to (F): (A) a protein which contains the amino acid sequence represented by SEQ ID NO: 2; (B) a protein which contains an amino acid sequence having a 90% or higher homology with the amino acid sequence represented by SEQ ID NO: 2 and has a D-glucuronyl C5-epimerase activity; (C) a protein which contains an amino acid sequence having the deletion substitution addition or insertion of one or several amino acid residues in the amino acid sequence represented by SEQ ID NO: 2 and has a D-glucuronyl C5-epimerase activity; (D) a protein which contains the amino acid sequence represented by SEQ ID NO: 5; (E) a protein which contains an amino acid sequence having a 90% or higher homology with the amino acid sequence represented by SEQ ID NO: 5 and has a D-glucuronyl C5-epimerase activity; and (F) a protein which contains an amino acid sequence having the deletion substitution addition or insertion of one or several amino acid residues in the amino acid sequence represented by SEQ ID NO: 5 and has a D-glucuronyl C5-epimerase activity.
1. A method for producing a heparosan compound having an isomerized hexuronic acid residue, said method comprising 5 producing the heparosan compound having the isomerized hexuronic acid residue from a heparosan compound in the presence of a protein selected from the group of consisting of the following (A) to (F): (A) a protein comprising the amino acid sequence of SEQ 10 ID No: 2; (B) a protein which comprises an amino acid sequence having 80% or more homology to the amino acid sequence of SEQ ID No:2 and has a D-glucuronyl C5-epimerase activity; (C) a protein which comprises an amino acid sequence 15 having one or several deleted, substituted, added or inserted amino acid residues in the amino acid sequence of SEQ ID No:2 and has a D-glucuronyl C5-epimerase activity; (D) a protein comprising the amino acid sequence of SEQ ID NO: 5; 20 (E) a protein which comprises an amino acid sequence having 80% or more homology to the amino acid sequence of SEQ ID No:5 and has a D-glucuronyl C5-epimerase activity; and (F) a protein which comprises an amino acid sequence 25 having one or several deleted, substituted, added or inserted amino acid residues in the amino acid sequence of SEQ ID No:5 and has a D-glucuronyl C5-epimerase activity.
2. The method according to claim 1, 30 wherein the protein (B) is (B1) a protein which comprises an amino acid sequence having 90% or more homology to the amino acid sequence of SEQ ID No:2 and has a D-glucuronyl C5-epimerase activity, and 65 wherein the protein (E) is (E') a protein which comprises an amino acid sequence having 90% or more homology to the amino acid sequence of SEQ ID No:5 and has a D-glucuronyl C5-epimerase activity.
3. The method according to claim 1 or 2, wherein said protein is a protein selected from the group consisting of the following (El) to (Fl): 10 (El) a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:56, 59, 62, 65 and 68; 15 (E2) a protein which comprises an amino acid sequence having 95% or more homology to an amino acid sequence selected from the group consisting of SEQ ID NOS:59, 62, 65 and 68 and has a D-glucuronyl C5-epimerase activity; and (Fl) a protein which comprises an amino acid sequence having 1 to 25 deleted, substituted, added or inserted amino acid residues in an amino acid sequence selected from the group consisting of SEQ ID NOS:59, 62, 65 and 68 and has a D-glucuronyl C5-epimerase activity.
4. The method according to any one of claims 1 to 3, wherein said protein is derived from zebrafish. 25 5. The method according to any one of claims 1 to 4, wherein the heparosan compound having the isomerized hexuronic acid residue is produced in the presence of a transformed microorganism producing said protein or an extract thereof. 30
6. The method according to claim 5, wherein said transformed microorganism is a host cell comprising an expression unit comprising a polynucleotide selected from 66 the group consisting of the following (a) to (j) and a promoter operably linked thereto: (a) a polynucleotide comprising the nucleotide sequence of SEQ ID N0:1; 5 (b) a polynucleotide which comprises a nucleotide sequence having 80% or more homology to the nucleotide sequence of SEQ ID NO:l and encodes a protein having a D-glucuronyl C5-epimerase activity; (c) a polynucleotide which hybridizes with a 10 polynucleotide consisting of the nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO:l under the stringent conditions and encodes a protein having a D-glucuronyl C5-epimerase activity; (d) a polynucleotide comprising the nucleotide sequence 15 of SEQ ID NO: 3; (e) a polynucleotide which comprises a nucleotide sequence having 80% or more homology to the nucleotide sequence of SEQ ID NO:3 and encodes a protein having a D- glucuronyl C5-epimerase activity; 20 (f) a polynucleotide which hybridizes with a polynucleotide consisting of the nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO:3 under the stringent conditions and encodes a protein having a D-glucuronyl C5-epimerase activity; 25 (g) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 4; (h) a polynucleotide which comprises a nucleotide sequence having 80% or more homology to the nucleotide sequence of SEQ ID NO:4 and encodes a protein having a D- 30 glucuronyl C5-epimerase activity; (i) a polynucleotide which hybridizes with a polynucleotide consisting of the nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO:4 67 under the stringent conditions and encodes a protein having a D-glucuronyl C5-epimerase activity; and (j) a degenerate mutant of a polynucleotide selected from the group consisting of (a) to (i). 5
7. The method according to claim 6, wherein the polynucleotide (b) is (b') a polynucleotide which comprises a nucleotide sequence having 90% or more homology to the nucleotide sequence of SEQ ID 10 NO:l and encodes a protein having a D-glucuronyl C5-epimerase activity, wherein the polynucleotide (e) is (e1) a polynucleotide which comprises a nucleotide sequence having 90% or more homology to the nucleotide sequence of SEQ ID 15 NO:3 and encodes a protein having a D-glucuronyl C5-epimerase activity, and wherein the polynucleotide (h) is (h') a polynucleotide which comprises a nucleotide sequence having 90% or more homology to the nucleotide sequence of SEQ ID 20 NO:4 and encodes a protein having a D-glucuronyl C5-epimerase activity.
8. The method according to claim 6 or 7, wherein said polynucleotide is a polynucleotide selected from the group 25 consisting of the following (el) to (jl): (el) a polynucleotide comprising a nucleotide sequence selected from the group consisting of SEQ ID NOS:55, 58, 61, 64 and 67; (e2) a polynucleotide which comprises a nucleotide 30 sequence having 95% or more homology to a nucleotide sequence selected from the group consisting of SEQ ID NOS:58, 61, 64 and 67 and encodes a protein having a D-glucuronyl C5-epimerase activity; and 68 (jl) a degenerate mutant of the polynucleotide (el) or (e2) .
9. The method according to any one of claims 6 to 8, 5 wherein said transformed microorganism is a bacterium belonging to genus Escherichia.
10. The method according to claim 9, wherein said transformed microorganism is Escherichia coli. 10
11. The method according to any one of claims 1 to 10, wherein said heparosan compound is an N-sulfated heparosan.
12. The method according to any one of claims 1 to 11, 15 wherein said heparosan compound is a low-molecularized heparosan.
13. A method for producing a heparan sulfate, said method comprising subjecting a heparosan to a 20 treatment comprising C5-epimerization of a hexuronic acid residue, 2-O-sulfation of a hexuronic acid residue, N-deacetylation of an a-D-glucosamine residue, N-sulfation of an a-D-glucosamine residue, 3-O-sulfation of an a-D-glucosamine residue, and 6-O-sulfation of an a-D-25 glucosamine residue to produce the heparan sulfate, wherein the C5-epimerization is performed in the presence of a protein selected from the following (A) to (F) : (A) a protein comprising the amino acid sequence of SEQ 30 ID NO:2; (B) a protein which comprises an amino acid sequence having 80% or more identity to the amino acid sequence of SEQ ID NO:2 and has a D-glucuronyl C5-epimerase activity; 69 (C) a protein which comprises an amino acid sequence having one or several deleted, substituted, added or inserted amino acid residues in the amino acid sequence of SEQ ID NO:2 and has a D-glucuronyl C5-epimerase activity; 5 (D) a protein comprising the amino acid sequence of SEQ ID N0:5; (E) a protein which comprises an amino acid sequence having 80% or more identity to the amino acid sequence of SEQ ID NO:5 and has a D-glucuronyl C5-epimerase activity; 10 and (F) a protein which comprises an amino acid sequence having one or several deleted, substituted, added or inserted amino acid residues in the amino acid sequence of SEQ ID NO:5 and has a D-glucuronyl C5-epimerase activity. 15
14. The method according to claim 13, wherein the protein (B) is (B') a protein which comprises an amino acid sequence having 90% or more identity to the amino acid sequence of SEQ ID NO:2 and has 20 a D-glucuronyl C5-epimerase activity, and wherein the protein (E) is (E') a protein which comprises an amino acid sequence having 90% or more identity to the amino acid sequence of SEQ ID NO:5 and has a D-glucuronyl C5-epimerase activity. 25
15. The method according to claim 13 or 14, wherein said protein is selected from the group consisting of the following (El) to (Fl): (El) a protein comprising an amino acid sequence selected 30 from the group consisting of SEQ ID NOS:56, 59, 62, 65 and 68; (E2) a protein which comprises an amino acid sequence having 95% or more homology to an amino acid sequence 70 selected from the group consisting of SEQ ID NOS:59, 62, 65 and 68, and has a D-glucuronyl C5-epimerase activity; and (Fl) a protein which comprises an amino acid sequence having 1 to 25 deleted, substituted, added or inserted 5 amino acid residues in an amino acid sequence selected from the group consisting of SEQ ID NOS:59, 62, 65 and 68 and has a D-glucuronyl C5-epimerase activity.
16. The method according to any one of claims 13 to 15, 10 wherein the treatment further comprises decomposition of a heparosan into small molecules.
17. A protein selected from the group consisting of the following (El) to (Fl): 15 (El) a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:56, 59, 62, 65 and 68; (E2) a protein which comprises an amino acid sequence having 95% or more homology to an amino acid sequence 20 selected from the group consisting of SEQ ID NOS:59, 62, 65 and 68 and has a D-glucuronyl C5-epimerase activity; and (Fl) a protein which comprises an amino acid sequence having 1 to 25 deleted, substituted, added or inserted amino acid residues in an amino acid sequence selected from 25 the group consisting of SEQ ID NOS:59, 62, 65 and 68 and has a D-glucuronyl C5-epimerase activity. 71
WE CLAIM:
1. A method for producing a heparosan compound having an
isomerized hexuronic acid residue, said method comprising
5 producing the heparosan compound having the isomerized hexuronic acid residue from a heparosan compound in the presence of a protein selected from the group of consisting of the following (A) to (F):
(A) a protein comprising the amino acid sequence of SEQ
10 ID No: 2;
(B) a protein which comprises an amino acid sequence
having 80% or more homology to the amino acid sequence of
SEQ ID No:2 and has a D-glucuronyl C5-epimerase activity;
(C) a protein which comprises an amino acid sequence
15 having one or several deleted, substituted, added or
inserted amino acid residues in the amino acid sequence of SEQ ID No:2 and has a D-glucuronyl C5-epimerase activity;
(D) a protein comprising the amino acid sequence of SEQ
ID NO: 5;
20 (E) a protein which comprises an amino acid sequence
having 80% or more homology to the amino acid sequence of SEQ ID No:5 and has a D-glucuronyl C5-epimerase activity; and
(F) a protein which comprises an amino acid sequence
25 having one or several deleted, substituted, added or
inserted amino acid residues in the amino acid sequence of SEQ ID No:5 and has a D-glucuronyl C5-epimerase activity.
2. The method according to claim 1,
30 wherein the protein (B) is (B1) a protein which comprises an amino acid sequence having 90% or more homology to the amino acid sequence of SEQ ID No:2 and has a D-glucuronyl C5-epimerase activity, and
65
wherein the protein (E) is (E') a protein which comprises an amino acid sequence having 90% or more homology to the amino acid sequence of SEQ ID No:5 and has a D-glucuronyl C5-epimerase activity.
3. The method according to claim 1 or 2, wherein said
protein is a protein selected from the group consisting of
the following (El) to (Fl):
10
(El) a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:56, 59, 62, 65 and 68;
15
(E2) a protein which comprises an amino acid sequence having 95% or more homology to an amino acid sequence selected from the group consisting of SEQ ID NOS:59, 62, 65 and 68 and has a D-glucuronyl C5-epimerase activity; and
(Fl) a protein which comprises an amino acid sequence having 1 to 25 deleted, substituted, added or inserted amino acid residues in an amino acid sequence selected from the group consisting of SEQ ID NOS:59, 62, 65 and 68 and has a D-glucuronyl C5-epimerase activity.
4. The method according to any one of claims 1 to 3,
wherein said protein is derived from zebrafish.
25 5. The method according to any one of claims 1 to 4, wherein the heparosan compound having the isomerized hexuronic acid residue is produced in the presence of a transformed microorganism producing said protein or an extract thereof.
30
6. The method according to claim 5, wherein said transformed microorganism is a host cell comprising an expression unit comprising a polynucleotide selected from
66
the group consisting of the following (a) to (j) and a promoter operably linked thereto:
(a) a polynucleotide comprising the nucleotide sequence of SEQ ID N0:1; 5 (b) a polynucleotide which comprises a nucleotide
sequence having 80% or more homology to the nucleotide sequence of SEQ ID NO:l and encodes a protein having a D-glucuronyl C5-epimerase activity;
(c) a polynucleotide which hybridizes with a
10 polynucleotide consisting of the nucleotide sequence
complementary to the nucleotide sequence of SEQ ID NO:l under the stringent conditions and encodes a protein having a D-glucuronyl C5-epimerase activity;
(d) a polynucleotide comprising the nucleotide sequence
15 of SEQ ID NO: 3;
(e) a polynucleotide which comprises a nucleotide
sequence having 80% or more homology to the nucleotide
sequence of SEQ ID NO:3 and encodes a protein having a D-
glucuronyl C5-epimerase activity;
20 (f) a polynucleotide which hybridizes with a
polynucleotide consisting of the nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO:3 under the stringent conditions and encodes a protein having a D-glucuronyl C5-epimerase activity;
25 (g) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 4;
(h) a polynucleotide which comprises a nucleotide sequence having 80% or more homology to the nucleotide sequence of SEQ ID NO:4 and encodes a protein having a D-
30 glucuronyl C5-epimerase activity;
(i) a polynucleotide which hybridizes with a polynucleotide consisting of the nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO:4
67
under the stringent conditions and encodes a protein having a D-glucuronyl C5-epimerase activity; and
(j) a degenerate mutant of a polynucleotide selected from the group consisting of (a) to (i). 5
7. The method according to claim 6,
wherein the polynucleotide (b) is (b') a
polynucleotide which comprises a nucleotide sequence having 90% or more homology to the nucleotide sequence of SEQ ID
10 NO:l and encodes a protein having a D-glucuronyl C5-epimerase activity,
wherein the polynucleotide (e) is (e1) a polynucleotide which comprises a nucleotide sequence having 90% or more homology to the nucleotide sequence of SEQ ID
15 NO:3 and encodes a protein having a D-glucuronyl C5-epimerase activity, and
wherein the polynucleotide (h) is (h') a polynucleotide which comprises a nucleotide sequence having 90% or more homology to the nucleotide sequence of SEQ ID
20 NO:4 and encodes a protein having a D-glucuronyl C5-epimerase activity.
8. The method according to claim 6 or 7, wherein said
polynucleotide is a polynucleotide selected from the group
25 consisting of the following (el) to (jl):
(el) a polynucleotide comprising a nucleotide sequence selected from the group consisting of SEQ ID NOS:55, 58, 61, 64 and 67;
(e2) a polynucleotide which comprises a nucleotide 30 sequence having 95% or more homology to a nucleotide sequence selected from the group consisting of SEQ ID NOS:58, 61, 64 and 67 and encodes a protein having a D-glucuronyl C5-epimerase activity; and
68
(jl) a degenerate mutant of the polynucleotide (el) or (e2) .
9. The method according to any one of claims 6 to 8,
5 wherein said transformed microorganism is a bacterium
belonging to genus Escherichia.
10. The method according to claim 9, wherein said
transformed microorganism is Escherichia coli.
10
11. The method according to any one of claims 1 to 10,
wherein said heparosan compound is an N-sulfated heparosan.
12. The method according to any one of claims 1 to 11,
15 wherein said heparosan compound is a low-molecularized
heparosan.
13. A method for producing a heparan sulfate,
said method comprising subjecting a heparosan to a 20 treatment comprising C5-epimerization of a hexuronic acid residue, 2-O-sulfation of a hexuronic acid residue, N-deacetylation of an a-D-glucosamine residue, N-sulfation of an a-D-glucosamine residue, 3-O-sulfation of an a-D-glucosamine residue, and 6-O-sulfation of an a-D-25 glucosamine residue to produce the heparan sulfate,
wherein the C5-epimerization is performed in the presence of a protein selected from the following (A) to (F) :
(A) a protein comprising the amino acid sequence of SEQ
30 ID NO:2;
(B) a protein which comprises an amino acid sequence
having 80% or more identity to the amino acid sequence of
SEQ ID NO:2 and has a D-glucuronyl C5-epimerase activity;
69
(C) a protein which comprises an amino acid sequence having one or several deleted, substituted, added or inserted amino acid residues in the amino acid sequence of SEQ ID NO:2 and has a D-glucuronyl C5-epimerase activity; 5 (D) a protein comprising the amino acid sequence of SEQ ID N0:5;
(E) a protein which comprises an amino acid sequence
having 80% or more identity to the amino acid sequence of
SEQ ID NO:5 and has a D-glucuronyl C5-epimerase activity;
10 and
(F) a protein which comprises an amino acid sequence
having one or several deleted, substituted, added or
inserted amino acid residues in the amino acid sequence of
SEQ ID NO:5 and has a D-glucuronyl C5-epimerase activity.
15
14. The method according to claim 13,
wherein the protein (B) is (B') a protein which comprises an amino acid sequence having 90% or more identity to the amino acid sequence of SEQ ID NO:2 and has 20 a D-glucuronyl C5-epimerase activity, and
wherein the protein (E) is (E') a protein which comprises an amino acid sequence having 90% or more identity to the amino acid sequence of SEQ ID NO:5 and has a D-glucuronyl C5-epimerase activity. 25
15. The method according to claim 13 or 14, wherein said
protein is selected from the group consisting of the
following (El) to (Fl):
(El) a protein comprising an amino acid sequence selected 30 from the group consisting of SEQ ID NOS:56, 59, 62, 65 and 68;
(E2) a protein which comprises an amino acid sequence having 95% or more homology to an amino acid sequence
70
selected from the group consisting of SEQ ID NOS:59, 62, 65 and 68, and has a D-glucuronyl C5-epimerase activity; and
(Fl) a protein which comprises an amino acid sequence having 1 to 25 deleted, substituted, added or inserted 5 amino acid residues in an amino acid sequence selected from the group consisting of SEQ ID NOS:59, 62, 65 and 68 and has a D-glucuronyl C5-epimerase activity.
16. The method according to any one of claims 13 to 15,
10 wherein the treatment further comprises decomposition of a
heparosan into small molecules.
17. A protein selected from the group consisting of the
following (El) to (Fl):
15 (El) a protein comprising an amino acid sequence selected
from the group consisting of SEQ ID NOS:56, 59, 62, 65 and
68;
(E2) a protein which comprises an amino acid sequence
having 95% or more homology to an amino acid sequence 20 selected from the group consisting of SEQ ID NOS:59, 62, 65
and 68 and has a D-glucuronyl C5-epimerase activity; and (Fl) a protein which comprises an amino acid sequence
having 1 to 25 deleted, substituted, added or inserted
amino acid residues in an amino acid sequence selected from 25 the group consisting of SEQ ID NOS:59, 62, 65 and 68 and
has a D-glucuronyl C5-epimerase activity.
71
| # | Name | Date |
|---|---|---|
| 1 | 201947028948.pdf | 2019-07-18 |
| 2 | 201947028948-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [18-07-2019(online)].pdf | 2019-07-18 |
| 3 | 201947028948-STATEMENT OF UNDERTAKING (FORM 3) [18-07-2019(online)].pdf | 2019-07-18 |
| 4 | 201947028948-SEQUENCE LISTING(PDF) [18-07-2019(online)].pdf | 2019-07-18 |
| 5 | 201947028948-SEQUENCE LISTING [18-07-2019(online)].txt | 2019-07-18 |
| 6 | 201947028948-PRIORITY DOCUMENTS [18-07-2019(online)].pdf | 2019-07-18 |
| 7 | 201947028948-POWER OF AUTHORITY [18-07-2019(online)].pdf | 2019-07-18 |
| 8 | 201947028948-FORM 1 [18-07-2019(online)].pdf | 2019-07-18 |
| 9 | 201947028948-DRAWINGS [18-07-2019(online)].pdf | 2019-07-18 |
| 10 | 201947028948-DECLARATION OF INVENTORSHIP (FORM 5) [18-07-2019(online)].pdf | 2019-07-18 |
| 11 | 201947028948-COMPLETE SPECIFICATION [18-07-2019(online)].pdf | 2019-07-18 |
| 12 | 201947028948-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [18-07-2019(online)].pdf | 2019-07-18 |
| 13 | 201947028948-Proof of Right (MANDATORY) [11-11-2019(online)].pdf | 2019-11-11 |
| 14 | Correspondence by Agent_Form1_14-11-2019.pdf | 2019-11-14 |
| 15 | 201947028948-FORM 3 [30-12-2019(online)].pdf | 2019-12-30 |
| 16 | 201947028948-FORM 18 [02-11-2020(online)].pdf | 2020-11-02 |
| 17 | 201947028948-FORM 3 [04-11-2020(online)].pdf | 2020-11-04 |
| 18 | 201947028948-PRE GRANT OPPOSITION DOCUMENT [29-06-2022(online)].pdf | 2022-06-29 |
| 19 | 201947028948_Pre Grant Opposition Notice_03-03-2023.pdf | 2023-03-03 |
| 20 | 201947028948-FER.pdf | 2023-03-06 |
| 21 | 201947028948-Statement and Evidence [02-06-2023(online)].pdf | 2023-06-02 |
| 22 | 201947028948-PETITION UNDER RULE 137 [02-06-2023(online)].pdf | 2023-06-02 |
| 23 | 201947028948-OTHERS [02-06-2023(online)].pdf | 2023-06-02 |
| 24 | 201947028948-MARKED COPIES OF AMENDEMENTS [02-06-2023(online)].pdf | 2023-06-02 |
| 25 | 201947028948-Information under section 8(2) [02-06-2023(online)].pdf | 2023-06-02 |
| 26 | 201947028948-FORM 3 [02-06-2023(online)].pdf | 2023-06-02 |
| 27 | 201947028948-FORM 13 [02-06-2023(online)].pdf | 2023-06-02 |
| 28 | 201947028948-FER_SER_REPLY [02-06-2023(online)].pdf | 2023-06-02 |
| 29 | 201947028948-COMPLETE SPECIFICATION [02-06-2023(online)].pdf | 2023-06-02 |
| 30 | 201947028948-CLAIMS [02-06-2023(online)].pdf | 2023-06-02 |
| 31 | 201947028948-ABSTRACT [02-06-2023(online)].pdf | 2023-06-02 |
| 32 | 201947028948-PreGrant-HearingNotice-(HearingDate-17-04-2024).pdf | 2024-03-01 |
| 33 | 201947028948-Correspondence to notify the Controller [08-04-2024(online)].pdf | 2024-04-08 |
| 34 | 201947028948-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [12-04-2024(online)].pdf | 2024-04-12 |
| 35 | 201947028948-PreGrant-ExtendedHearingNotice-(HearingDate-27-06-2024).pdf | 2024-05-13 |
| 36 | 201947028948-Correspondence to notify the Controller [20-06-2024(online)].pdf | 2024-06-20 |
| 37 | 201947028948-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [24-06-2024(online)].pdf | 2024-06-24 |
| 38 | 201947028948-PreGrant-ExtendedHearingNotice-(HearingDate-04-09-2024)-1100.pdf | 2024-08-01 |
| 39 | 201947028948-ANY SUPPORTING DOCUMENT [28-08-2024(online)].pdf | 2024-08-28 |
| 40 | 201947028948-FORM-26 [30-08-2024(online)].pdf | 2024-08-30 |
| 41 | 201947028948-ANY SUPPORTING DOCUMENT [30-08-2024(online)].pdf | 2024-08-30 |
| 42 | 201947028948-Written submissions and relevant documents [19-09-2024(online)].pdf | 2024-09-19 |
| 43 | 201947028948-Written submissions and relevant documents [19-09-2024(online)]-2.pdf | 2024-09-19 |
| 44 | 201947028948-Written submissions and relevant documents [19-09-2024(online)]-1.pdf | 2024-09-19 |
| 45 | 201947028948-Retyped Pages under Rule 14(1) [19-09-2024(online)].pdf | 2024-09-19 |
| 46 | 201947028948-Annexure [19-09-2024(online)].pdf | 2024-09-19 |
| 47 | 201947028948-2. Marked Copy under Rule 14(2) [19-09-2024(online)].pdf | 2024-09-19 |
| 1 | Doc1E_28-02-2023.pdf |